Prior to joining SOLIUS, Linda spent two decades in the health technology industry leading and consulting on complex R & D projects, several of which have been disruptive technologies requiring unique approaches to product design, development and marketplace positioning. Her industry experience ranges from working with early stage companies through IPO – managing several consecutive product life cycles – to consulting with Fortune 500 companies in the wireless health innovation arena. With deep expertise in Class II FDA regulated products, Linda has played a key role in navigating the regulatory phases required to bring a product to market. Her industry experience includes go-to-market strategies for medical devices, wireless medical and handheld wireless systems, HIPAA compliant cloud based systems, custom software applications, RF and cellular communications. Linda holds a BS in Clinical Physiology from Northeastern University. She spent the first decade of her career applying evidence-based practices and contributing to clinical research trials in Harvard Medical School institutions such as Beth Israel Deaconess Medical Center and Massachusetts General Hospital.